FFRangio System vs Analytic for Hemodynamic Instability (AHI)

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

FFRangio System

by CathWorks (acquired by Medtronic)

Analytic for Hemodynamic Instability (AHI)

by Fifth Eye Inc.

AI Verdict

Tool A is designed for interventional cardiologists to optimize PCI decisions for coronary artery disease using wire-free FFR guidance in the cath lab. Tool B, on the other hand, is a clinical decision support system for continuous monitoring of in-hospital patients, predicting hemodynamic instability hours in advance using ECG data. While both leverage AI in cardiology, their distinct focus areas—procedural optimization versus proactive patient monitoring—make them complementary rather than directly competitive.

Choose FFRangio System if…

Choose the FFRangio System if your cardiology department requires advanced, non-invasive physiological guidance to optimize percutaneous coronary intervention (PCI) decisions. This system is ideal for cath labs seeking to accurately assess multi-vessel coronary artery disease severity and confirm treatment efficacy without the need for invasive pressure wires or vasoactive drugs. It provides real-time FFR values and lesion impact analysis to streamline PCI procedures.

View FFRangio System →

Choose Analytic for Hemodynamic Instability (AHI) if…

Choose the Analytic for Hemodynamic Instability (AHI) system if your hospital needs an AI-driven solution for continuous, early detection of hemodynamic instability in adult in-hospital patients. This tool is best suited for critical care, emergency medicine, or general ward settings where proactive patient monitoring and early warnings, hours before traditional vital signs indicate deterioration, can significantly improve patient outcomes and reduce nurse workload.

View Analytic for Hemodynamic Instability (AHI) →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	FFRangio System	Analytic for Hemodynamic Instability (AHI)
Pricing	Contact vendor for pricing information.	Unknown
Deployment	SaaS, on-prem, hybrid	Integrates with existing hospital ECGs and can be deployed through platforms like Medical Informatics Corp.'s Sickbay™ and VitalConnect's remote patient monitoring solution.
BAA Available	Yes AI-estimated	Unknown
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Unknown	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Analytic for Hemodynamic Instability (AHI)

Tool B (AHI) emphasizes an easy-to-interpret visual interface with red, yellow, and green indicators, and is accessible via any browser-enabled device, which offers greater flexibility and ease of access for a broader range of healthcare professionals. Its design aims to reduce nurse surveillance burden and streamline workflow, directly enhancing usability for busy clinical staff. Tool A (FFRangio) focuses on an intuitive user interface and seamless integration within the specialized cath lab environment.

Clinical Value

Analytic for Hemodynamic Instability (AHI)

Both tools are FDA-cleared and offer significant clinical value. However, Tool B (AHI) provides early warnings for hemodynamic instability, a critical and potentially life-threatening condition, hours ahead of traditional vital signs (up to 26 hours for AHI-PI), enabling proactive intervention across a wide range of in-hospital patients. Tool A (FFRangio) offers wire-free and drug-free FFR guidance, optimizing PCI decisions in cardiology, which is also valuable but more specialized.

Pricing & Value

Tie

Both Tool A and Tool B explicitly state 'contact for pricing' or 'contact vendor' in their specifications. Without any transparent pricing information or detailed cost-benefit analyses provided, it is impossible to definitively compare their financial value propositions. Therefore, a tie is appropriate for this dimension.

Enterprise Readiness

Analytic for Hemodynamic Instability (AHI)

Tool B (AHI) is deployed as Software as a Medical Device (SaMD) and integrates with existing in-hospital monitoring platforms, accessible via any browser-enabled device, suggesting easier and more flexible enterprise-wide deployment and scalability. Tool A (FFRangio) is an on-premise system that integrates with specific cath lab equipment, which implies a more specialized and potentially complex hardware-dependent integration, although its ISO 27001 certification is a strong point for information security.

Innovation

Analytic for Hemodynamic Instability (AHI)

While Tool A (FFRangio) offers significant innovation by providing wire-free and drug-free 3D FFR guidance, transforming coronary physiology assessment, Tool B (AHI) presents a highly innovative capability by predicting hemodynamic instability up to 26 hours in advance using continuous ECG data. This predictive power for a critical condition across a broad patient population represents a potentially more transformative advancement in proactive patient care and critical event prevention.

Support & Docs

Tie

The provided structured facts do not contain information regarding support or documentation for either tool. Web searches for both products' support and documentation also did not yield sufficient public details to make a comparative judgment on the quality or availability of their support services or documentation. CathWorks mentions a post-sales technical service support partnership with Quest International, and Fifth Eye integrates with platforms like Sickbay, which may imply shared support, but direct comparative information is lacking.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	FFRangio System	Analytic for Hemodynamic Instability (AHI)
Name	FFRangio System	Analytic for Hemodynamic Instability (AHI)
Company	CathWorks	Fifth Eye
Description	The CathWorks FFRangio System delivers wire-free and drug-free 3D FFR guidance, providing accurate multi-vessel FFR results and advanced insights to quickly optimize and confirm PCI decisions for patients with coronary artery disease.	Fifth Eye's AHI System is an FDA-cleared, AI-driven clinical decision support software that continuously monitors adult in-hospital patients for signs of hemodynamic instability, providing early warnings hours ahead of traditional vital signs.
Tagline	A New Era in Coronary Physiology	Predicting hemodynamic instability earlier than vital signs for proactive patient care.
Specialties	Cardiology	Cardiology, Critical Care, Emergency Medicine
Key Features (Example)	Real-time FFRangio values at every point on the coronary tree	Real-time clinical analytics based on physiologic waveforms

Videos

Demos, reviews, and walkthroughs featuring FFRangio System and Analytic for Hemodynamic Instability (AHI).

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What is the primary clinical application of each tool?

The FFRangio System provides wire-free and drug-free 3D FFR guidance to optimize PCI decisions for patients with coronary artery disease. The AHI System continuously monitors adult in-hospital patients for signs of hemodynamic instability, providing early warnings hours ahead of traditional vital signs.

What type of data does each system utilize for its analysis?

The FFRangio System uses routine X-rays acquired during a diagnostic angiogram procedure and artificial intelligence for angiogram analysis to create a 3D model of the coronary arteries. The AHI System utilizes continuous ECG lead II data and physiologic waveforms for its real-time clinical analytics.

How do these tools integrate into existing clinical workflows and hospital infrastructure?

The FFRangio System is an on-premise solution that integrates seamlessly with cath lab equipment, C-arm angiography systems, and PACS. The AHI System is a Software as a Medical Device (SaMD) that integrates into existing in-hospital monitoring platforms and is accessible via any browser-enabled device.

What are the key differences in the insights or guidance provided by each tool?

The FFRangio System provides real-time FFRangio values at every point on the coronary tree, simulated pullback curves, and a Lesion Impact feature to assess residual ischemia. The AHI System offers early warnings of hemodynamic instability, predicting it hours ahead of traditional vital signs, and presents these insights as easy-to-interpret visual indicators.

For which patient populations or clinical settings is each tool designed?

The FFRangio System is designed for patients with coronary artery disease undergoing assessment for percutaneous coronary intervention (PCI) in the cath lab. The AHI System is intended for continuous monitoring of adult in-hospital patients (18 years or older) receiving continuous physiological monitoring with ECG, applicable in critical care and emergency medicine settings.

Does either tool reduce the need for invasive procedures or monitoring?

The FFRangio System eliminates the need for invasive pressure wires, drugs, or a guide catheter for FFR assessment, providing non-invasive FFR guidance from routine angiograms. The AHI System provides non-invasive continuous monitoring for hemodynamic instability using existing ECG data, which can reduce nurse surveillance burden and potentially the need for more intensive care.